Korean Hyaluronic Serum Import Due Diligence: 11 Questions Your Compliance Checklist Must Answer Before PO Release

on
🔗 Related: the complete guide is on Korea Industry Insights — kept up to date with certifications and contacts.
Korean hyaluronic ampoule serum 50ml PET bottle with US FDA compliance documents, Certificate of Analysis form, and quality inspection checklist on a white laboratory surface

Importing Korean hyaluronic ampoule serum into the US requires documented verification — not promises — that the manufacturing facility, the formula safety data, and the label structure all satisfy US regulatory requirements before you wire funds. This guide covers 11 compliance questions a US private-label brand or sourcing manager must answer, grouped by area: GMP evidence, CoA and testing data, MoCRA registration, claim substantiation, label compliance, and incoming inspection. Each question specifies what documentation counts as a complete answer.

Why Documents Matter More Than Supplier Promises

Many Korean cosmetic exporters carry some form of the documentation US buyers ask for. The gap between having a document and having a compliant one is where most first-order problems begin. A GMP certificate from an unaccredited issuer is not the equivalent of a third-party ISO 22716 audit. A Certificate of Analysis with no lot number is not a batch-specific release record.

US cosmetics import requirements changed substantially after the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The sections below move through six compliance areas in order, starting with the manufacturing facility and ending with the incoming shipment. Run through each before any funds are transferred.

4-Step Document Review Framework

  1. Request

    Ask for the specific document by name, lot number, issuer, and date range. Vague requests return vague documents. Name exactly what you need: the ISO 22716 certificate, not a 'GMP summary.'

  2. Review

    Cross-check every required field against the applicable standard — ISO 22716 for GMP, FDA CFR for labeling, USP <51> or ISO 11930 for PET. A document missing a required field is incomplete. Request it again.

  3. Verify

    Independently confirm at least one item per compliance area. Look up the MoCRA registration number in FDA Cosmetics Direct. Check the GMP certifier name online. Verification by a second source is not optional.

  4. Decide

    Three outcomes only: Accept and proceed, Request revision and re-review, or Stop the purchase order. Two or more unresolved items means Stop — not proceed and resolve post-shipment.

GMP and Facility Verification Questions

Can you name the accredited certification body that issued the GMP certificate?

For Korean cosmetic manufacturers, the applicable standard is ISO 22716:2007. According to the International Organization for Standardization, ISO 22716 covers production, control, storage, and shipment of cosmetic products and is the globally accepted GMP benchmark for the industry. Ask for the full certificate — not a summary — along with the certifying body's name and the validity dates. A self-declaration does not satisfy this requirement, and a certificate that omits the issuing body name cannot be independently verified.

Has the manufacturing facility completed FDA MoCRA registration?

According to the FDA, MoCRA facility registration had a compliance deadline of December 29, 2023. Enforcement of this registration requirement started on July 1, 2024. Ask for the specific registration number for the manufacturing site, then verify it yourself in FDA Cosmetics Direct — do not accept the number without checking. According to Cosmeservice Regulatory, registrations require biennial renewal, and any facility changes must be updated in the registration within 60 days.

Who is the named US Responsible Person, and is there a written agreement in place?

The FDA defines the responsible person as the manufacturer, packer, or distributor whose name appears on the cosmetic label. According to Zignify Regulatory Compliance, non-US manufacturers must also designate a US Agent to serve as the official FDA contact point. Without a US Responsible Person named on the label, the product cannot legally be marketed in the US. This appointment must be documented before any purchase order is placed.

Certificate of Analysis and Testing Data Questions

What test results must appear on the batch CoA for a hyaluronic ampoule serum?

The Contract Laboratory Network identifies the required fields for a complete cosmetics CoA: product name, a specific batch or lot number, manufacturing and expiry dates, test outcomes for microbial limits (total aerobic count, yeast, mold), heavy metals, and residual solvents, specification limits showing pass or fail for each parameter, and a signature from an authorized member of the manufacturer's quality unit. Request the CoA that matches the specific lot being quoted. A generic or unsigned CoA does not confirm the quoted batch was tested and cleared before release.

What stability testing must the formula have completed before a first purchase order?

According to Zignify Regulatory Compliance, the minimum stability evidence for a cosmetic serum consists of an accelerated test report covering at minimum 3 months at elevated temperature and humidity, alongside real-time stability data running for at least 12 months. Both data sets are required components of MoCRA safety substantiation records the responsible person must maintain. A stated shelf life such as 24 months requires actual test data to support it — the figure alone is not self-validating. When a supplier has neither a completed accelerated report nor an active real-time study underway, they cannot substantiate any specific shelf life claim.

What does a compliant Preservative Efficacy Test report require for a paraben-free serum?

Eurofins Scientific notes that water-based cosmetics in multi-use packaging require challenge testing under either USP <51> or ISO 11930. The test must be conducted on the final finished formula using the specific preservative system in the product. A qualifying PET report documents the full organism challenge panel (bacteria, yeast, and mold introduced), the log reduction achieved at each measurement point, and whether the preservative system passed Criteria A or Criteria B under ISO 11930. Ingredient-level PET data from a raw material supplier does not substitute for a test on the finished formula.

Claim Substantiation Questions

What documentation supports a “24-hour hydration” claim?

J&J Consulting Group states that a hydration duration claim requires Corneometer-based testing — a device that measures skin moisture content — recorded at baseline and again at the 24-hour mark after application. Consumer self-assessment surveys can provide supporting data but do not replace the instrument reading. Ask for the full test report including raw data, not a marketing summary. Ingredient supplier monographs on hyaluronic acid do not substitute for finished-formula testing on this claim.

What does a supplier need to support a “clinically tested” or “95% naturally derived” claim?

According to J&J Consulting Group, a “clinically tested” claim requires a randomized controlled trial with a documented protocol, statistical significance, and a complete Product Information File — all conducted on the finished formula, not on individual ingredients. For percentage-based natural claims, the FDA has confirmed there is no statutory definition of “naturally derived” in US cosmetics law. A figure such as 95% naturally derived must be backed by a methodology document specifying what qualifies as “naturally derived” in the formula and how the percentage was calculated. No methodology means no substantiated claim.

Label Compliance and Packaging Checks

What does a US-compliant label for a Korean hyaluronic serum require?

The FDA's cosmetics labeling requirements (21 CFR Parts 700–740) and the Fair Packaging and Labeling Act together specify five elements that must appear on every US cosmetic label: a product identity statement on the principal display panel; net quantity of contents in both US and metric measurements; the name and street address of the US Responsible Person; an INCI ingredient list ordered from highest to lowest predominance; and country of origin as required under the Tariff Act of 1930. Every mandatory element must be written in English. Request a full draft label before any production run and confirm each element before approving print files.

What fill-volume and packaging checks are required before releasing PO funds?

Blackbird Skincare advises that incoming fill-weight checks should confirm actual net contents against the declared amount in both US and metric units. For a 50ml PET bottle: weigh the net fill on a calibrated scale, run a drop test to verify the cap seal holds under physical impact, and inspect for visible leakage. For sealed bottle formats, a vacuum chamber test provides additional integrity verification. If the supplier cannot provide a filled, sealed pre-shipment sample before PO release, withhold funds until one is available — a sample not yet produced means fill parameters have not been confirmed at production scale.

When to Stop Your Purchase Order

A single open documentation item can often be resolved with a follow-up request. A cluster of open items — a supplier who cannot name their GMP certifier, provides a CoA missing the lot number, and has no MoCRA registration number to share — is not three unrelated oversights. It signals how that facility manages compliance overall.

Two or more unresolved items are grounds to pause the purchase order. Per QIMA, the standard is ANSI/ASQ Z1.4 at General Inspection Level II: AQL 2.5 for Major defects, AQL 4.0 for Minor, and AQL 0 for Critical. For a 4,000-unit lot, the standard sample size is 200 units at AQL 2.5. Confirm a third-party inspector before the shipment is packed.

The moment funds transfer is the point of maximum leverage in any sourcing relationship. Once a purchase order is placed, your ability to request changes or withhold payment narrows significantly.

Sources

Frequently Asked Questions

Is it the importer's responsibility to register the Korean manufacturing facility with the FDA?

No. MoCRA facility registration must be completed by the owner or operator of the manufacturing facility — the Korean manufacturer. Per the FDA, each facility engaged in cosmetic manufacturing must register separately. The US importer's obligation is different: as the party whose name appears on the product label as Responsible Person, you must confirm that registration is already complete before placing your first order. Registration status is verifiable in FDA Cosmetics Direct.

What is the minimum stability data acceptable for a first purchase order of Korean hyaluronic serum?

A workable minimum for a first PO is a completed 3-month accelerated stability report (run at elevated temperature and humidity) with a real-time stability study already underway. The 12-month real-time dataset cannot exist before an initial order, but an active ongoing study should be documented. A supplier with no completed report and no active study cannot support any specific shelf life claim under MoCRA safety substantiation requirements.

What does “General Inspection Level II, AQL 2.5” mean in practice for a 4,000-unit cosmetics shipment?

At AQL 2.5, General Inspection Level II, a third-party inspector examines 200 units from a 4,000-unit lot. Per QIMA, the lot passes if Major defects stay below the rejection threshold. Critical defects — contamination or a compromised seal — carry AQL 0: a single critical defect triggers rejection. Confirm a third-party inspector before the shipment is packed, not after it arrives.

Why must “clinically tested” be substantiated with finished-formula data specifically?

Because the performance of an ingredient in isolation does not predict how it behaves in a complete formulation. According to J&J Consulting Group, a “clinically tested” claim on a cosmetic must be substantiated by testing conducted on the actual finished product — at the specific concentrations used, in the full formula matrix, under conditions that reflect real consumer use. A raw material supplier's efficacy study does not establish what the finished serum does — FDA and FTC both require claims to be substantiated on the product as actually sold.

Ready to verify documentation for a Korean hyaluronic ampoule serum supplier before your first purchase order? Contact our sourcing and compliance review team at exportservice.cloud/inquiry to run through the checklist before funds are released.

Further reading: see the full guide, latest certifications, and direct contact on Korea Industry Insights.

Comments

Post a Comment